Global market for stem cells to reach $10.6 billion by 2018

August 6, 2014

Stem cell technology, among all other areas of bioscience, has produced a number of significant products in important therapeutic areas since the last decade. Because of the massive size of the market, developing a stem cell product line represents a considerable financial opportunity for research supply companies along with institutes involved in therapy and stem cord banking. With its global market expanding by double-digit every year, the stem cell market is estimated to grow substantially in the near future.

BCC Research provides an in-depth study of the global stem cells market through its report, The Global Market for Stem Cells. According to the report, the global market for stem cells reached $5.6 billion in 2013 and is expected to reach $6.2 billion in 2014. This is expected to grow to $10.2 billion by 2018, with a compound annual growth rate (CAGR) of 13.6% from 2013 to 2018.

RSS Feeds – Biotechnology

Use this report for, but not limited to, the following reasons:

  • Gain an overview of the global market for stem cells and related technologies
  • Analyze global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019
  • Access information on the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market
  • Examine strategies employed by companies specializing in this field to meet the challenges of a competitive and fast-growing market
  • Review comprehensive profiles of major players in the field


To order your copy of this report (or any of its chapters) or to download the report overview, click here.


US market for stem cell technologies in next 5 years

August 12, 2008

According to a new technical market research report, STEM CELL TECHNOLOGY: CURRENT APPLICATIONS AND FUTURE DIRECTIONS (BIO035C) from BCC Research, the domestic market for stem cell technology is expected to increase from $112.0 million in 2007 to $423.1 million in 2012, a compound annual growth rate (CAGR) of 30.5%

The market is divided into cellular therapeutics and therapeutic banking categories. Stem cells in therapeutic banking have the larger share of the market, worth $65.9 million in 2007 and expected to increase to $155.7 million in 2012, for a CAGR of 18.8%.

Cellular therapeutics should be the faster growing segment. Cellular therapeutics generated $46.1 million in 2007 and is expected to generate $267.4 million in 2012, a CAGR of 42.1%.

read more | digg story

Bookmark and Share